ContraVir Pharmaceuticals, Inc. and Philadelphia Stock Transfer, Inc., as Warrant Agent Warrant Agency Agreement Dated as of June , 2018Warrant Agency Agreement • June 4th, 2018 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of June , 2018 (“Agreement”), between ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Philadelphia Stock Transfer, Inc., a [ corporation (the “Warrant Agent”).
CONTRAVIR PHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENTDealer-Manager Agreement • June 4th, 2018 • ContraVir Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The following will confirm our agreement relating to the proposed rights offering (the “Rights Offering”) to be undertaken by ContraVir Pharmaceuticals, Inc., a Delaware corporation (the “Company”), pursuant to which the Company will distribute to holders of record of its common stock, par value $0.0001 per share (the “Common Stock”) and to holders of warrants issued in October 2015, April 2016 and April 2017, subscription rights (the “Rights”) to subscribe for up to an aggregate of [ ] units (the “Units”), each Unit consisting of one share of Preferred Stock (the “Rights Shares”) and [ ] warrants, with each warrant representing the right to purchase one share of Common Stock (the “Rights Warrants”), at a subscription price of $1,000 per Unit in cash (the “Subscription Price”).
